2000 Conditions Data Treatment 
The Cannigma
AUGUST 5, 2022
Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.
Puff Puff Post
DECEMBER 28, 2018
An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. With so many people affected by autism and incidence rates having increased by 119% between the years 2000 to 2010, it has gained the status of the quickest-growing developmental disability. The Current Treatments for Autism.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 28, 2021
Dr. Greenshaw is a Fellow of the Royal Society of Arts; a Fellow of the Canadian College of Neuropsychopharmacology (CCNP), for which he served as President from 2000-2002; and a fellow of the Collegium Internationale Neuropsychopharmacologicum (CINP). “We would like to extend a warm welcome to Andy as he joins the team at Entheon.
Veriheal
OCTOBER 29, 2020
billion was funded into cannabis research between 2000 and 2018. On the brighter side, Science Magazine has indicated that the funding for cannabis as an effective form of treatment and therapy is rising, however not as much as the funding for its adverse impacts are. How could we move the focus towards understanding the benefits?
Sensi Seeds
DECEMBER 10, 2018
They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. Consequently, they sorted the publications into three main groups: psychiatry, cancer treatment, and neurology.
The Cannigma
FEBRUARY 11, 2021
One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. That was shocking.”.
Cannabis Law Report
JULY 2, 2021
Novel therapies and psychedelic treatments are rapidly gaining popularity across large swathes of North America as the awareness of mental health disorders and the revolutionary effects of psychedelics in their treatment become more mainstream. Change is always hard, and the finance world is witness to this. HAVN Life Sciences Inc.
Expert insights. Personalized for you.
138 
Let's personalize your content